Goldman SachsGSPAST TOP PICKSep 22, 2014Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
(A Top Pick Oct 31/13. Up 16.71%.) As the premier investment bank globally, this made a lot of money taking companies public. At this price, you are buying the company at around BV. They will have the scope to increase their dividend once the federal authorities are convinced that their Tier 1 Capital is high enough.